Fidelity Investments’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$958M Buy
16,492,861
+2,658,347
+19% +$144M 0.05% 311
2025
Q4
$638M Buy
13,834,514
+1,324,581
+11% +$59.2M 0.03% 425
2025
Q3
$451M Buy
12,509,933
+358,883
+3% +$11.9M 0.02% 544
2025
Q2
$395M Sell
12,151,050
-361,184
-3% -$11.8M 0.02% 579
2025
Q1
$472M Sell
12,512,234
-579,414
-4% -$46.3M 0.03% 475
2024
Q4
$1.07B Sell
13,091,648
-2,709,019
-17% -$269M 0.06% 247
2024
Q3
$1.81B Sell
15,800,667
-366,673
-2% -$33M 0.11% 149
2024
Q2
$1.22B Sell
16,167,340
-93,819
-0.6% -$6.39M 0.08% 203
2024
Q1
$1.11B Buy
16,261,159
+2,047,794
+14% +$142M 0.07% 232
2023
Q4
$893M Buy
14,213,365
+136,328
+1% +$7.08M 0.07% 255
2023
Q3
$718M Buy
14,077,037
+20,801
+0.1% +$1.03M 0.06% 285
2023
Q2
$702M Buy
14,056,236
+2,247,671
+19% +$107M 0.06% 312
2023
Q1
$443M Buy
11,808,565
+1,639,283
+16% +$69.5M 0.04% 449
2022
Q4
$488M Buy
10,169,282
+1,272,085
+14% +$49.9M 0.05% 401
2022
Q3
$214M Buy
8,897,197
+383,791
+5% +$9.73M 0.02% 635
2022
Q2
$185M Buy
8,513,406
+136,464
+2% +$3.16M 0.02% 720
2022
Q1
$202M Buy
8,376,942
+502,592
+6% +$11M 0.02% 769
2021
Q4
$187M Buy
7,874,350
+45,965
+0.6% +$1.07M 0.01% 828
2021
Q3
$199M Buy
7,828,385
+121,576
+2% +$2.95M 0.02% 812
2021
Q2
$173M Buy
7,706,809
+7,666
+0.1% +$157K 0.01% 877
2021
Q1
$152M Buy
7,699,143
+56,738
+0.7% +$1.43M 0.01% 903
2020
Q4
$203M Buy
7,642,405
+1,266,642
+20% +$47.1M 0.02% 742
2020
Q3
$315M Buy
6,375,763
+1,669,004
+35% +$66.5M 0.03% 455
2020
Q2
$149M Buy
+4,706,759
New +$151M 0.02% 719

Other funds holding PCVX